March 25th 2025
The addition of the two larger-volume bioreactor sizes to Cytiva’s Xcellerex X-platform portfolio will allow scientists and researchers to scale up from 50 L to 2000 L to meet growing demand for clinical trials and regulatory approved products.
Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution
A plant-based expression system could provide greater speed and capacity at a comparatively low cost.
Comparing Fed-Batch Cell Culture Performances of Stainless Steel and Disposable Bioreactors
A case study to compare the performances of several types of mixing in disposable bags with stainless steel bioreactors.